Merck KGaA (0O14) Share Forecast & Price Target
0O14 Analyst Ratings
0O14 Stock 12 Month Forecast
Average Price Target
EUR 149.20▼(-1.22% Downside)Detailed List of Analyst Forecasts​
| Analyst Profile | Expert Firm | Price Target | Position | Upside / Downside | Action | Date | Follow | Article |
|---|---|---|---|---|---|---|---|---|
| Charles Pitman CFA | Barclays | EUR 150→EUR 160 | hold | 5.93%Upside | Reiterated | 10/28/26 | ||
| Falko Friedrichs | Deutsche Bank | EUR 141 | hold | -6.65%Downside | Reiterated | 10/28/26 | ||
| James Vane | Jefferies | EUR 144 | hold | -4.67%Downside | Reiterated | 10/19/26 | ||
| Matthew Weston | UBS | EUR 150 | hold | -0.70%Downside | Reiterated | 10/15/26 | ||
| Justin Smith | Bernstein | EUR 121→EUR 151 | hold | -0.03%Downside | Reiterated | 08/07/26 | ||
| Peter Spengler | DZ BANK AG | ― | buy | ― | Reiterated | 08/07/26 | ||
| Richard Vosser | J.P. Morgan | EUR 150 | buy | -0.70%Downside | Reiterated | 06/01/26 | ||
| David Evans | Kepler Capital | EUR 152 | buy | 0.63%Upside | Reiterated | 05/01/26 | ||
| James Quigley | Goldman Sachs | EUR 153→EUR 147 | buy | -2.68%Downside | Reiterated | 04/16/26 | ||
| Thibault Boutherin | Morgan Stanley | EUR 130→EUR 135 | hold | -10.63%Downside | Reiterated | 12/03/25 | ||
| Florent Cespedes | Bernstein | EUR 138→EUR 135 | hold | -10.63%Downside | Reiterated | 11/17/25 | ||
| Dylan Van Haaften | Stifel Nicolaus | EUR 105 | sell | -30.49%Downside | Reiterated | 11/13/25 |
| Analyst Profile | Date | Price Target | Position | Upside / Downside | Action | Follow | Article | Expert Firm |
|---|---|---|---|---|---|---|---|---|
| Charles Pitman CFA | 10/28/26 | EUR 150→EUR 160 | hold | 5.93%Upside | Reiterated | Barclays | ||
| Falko Friedrichs | 10/28/26 | EUR 141 | hold | -6.65%Downside | Reiterated | Deutsche Bank | ||
| James Vane | 10/19/26 | EUR 144 | hold | -4.67%Downside | Reiterated | Jefferies | ||
| Matthew Weston | 10/15/26 | EUR 150 | hold | -0.70%Downside | Reiterated | UBS | ||
| Justin Smith | 08/07/26 | EUR 121→EUR 151 | hold | -0.03%Downside | Reiterated | Bernstein | ||
| Peter Spengler | 08/07/26 | ― | buy | ― | Reiterated | DZ BANK AG | ||
| Richard Vosser | 06/01/26 | EUR 150 | buy | -0.70%Downside | Reiterated | J.P. Morgan | ||
| David Evans | 05/01/26 | EUR 152 | buy | 0.63%Upside | Reiterated | Kepler Capital | ||
| James Quigley | 04/16/26 | EUR 153→EUR 147 | buy | -2.68%Downside | Reiterated | Goldman Sachs | ||
| Thibault Boutherin | 12/03/25 | EUR 130→EUR 135 | hold | -10.63%Downside | Reiterated | Morgan Stanley | ||
| Florent Cespedes | 11/17/25 | EUR 138→EUR 135 | hold | -10.63%Downside | Reiterated | Bernstein | ||
| Dylan Van Haaften | 11/13/25 | EUR 105 | sell | -30.49%Downside | Reiterated | Stifel Nicolaus |
Best Analysts Covering Merck KGaA
Copying Peter Spengler's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +4.76% per trade.
Copying Peter Spengler's trades and holding each position for 1 Year would result in 74.36% of your transactions generating a profit, with an average return of +13.89% per trade.
Copying Peter Spengler's trades and holding each position for 2 Years would result in 79.49% of your transactions generating a profit, with an average return of +24.74% per trade.
0O14 Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 12 | 11 | 6 | 3 | 2 |
| Hold | 11 | 12 | 13 | 12 | 13 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 23 | 23 | 19 | 15 | 15 |
In the current month, 0O14 has received 2 Buy Ratings, 13 Hold Ratings, and 0 Sell Ratings. 0O14 average Analyst price target in the past 3 months is 149.20.
0O14 Financial Forecast
0O14 Earnings Forecast
Next quarter’s earnings estimate for 0O14 is EUR 2.18 with a range of EUR 2.14 to EUR 2.22. The previous quarter’s EPS was EUR 2.16. 0O14 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 50.49% of the time in the same period. In the last calendar year 0O14 has Performed in-line its overall industry.
0O14 Sales Forecast
Next quarter’s sales forecast for 0O14 is EUR 5.48B with a range of EUR 5.40B to EUR 5.54B. The previous quarter’s sales results were EUR 5.43B. 0O14 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 63.25% of the time in the same period. In the last calendar year 0O14 has Performed in-line its overall industry.